Scintillon Institute

Retrogen, Inc. is a San Diego-based company specializing in genomic and clinical services, offering a wide range of solutions for research and diagnostics. Their comprehensive services include next-generation sequencing, Sanger sequencing, molecular analysis, and clinical diagnostics for various areas such as women's health and infectious diseases. With a team of experts and state-of-the-art technology, Retrogen, Inc. provides accurate and reliable results for genetic testing, mutation analysis, sequence verification, and more. Committed to quality and innovation, they are a trusted partner for researchers, healthcare professionals, and individuals seeking advanced genomic solutions.Generated from the website

Biomyx Inc. is a private biotechnology company based in San Diego, California, established in 2002. The company focuses on advancing biosciences by creating innovative technologies that enhance the study of gene functions and improve the efficiency of biomedical research through high-quality, user-friendly products. Specializing in functional genomics, Biomyx offers a range of technologies and products that facilitate studies on gene functions in mammalian cells, particularly in cellular signal transduction. Their expertise also extends to molecular biology, cell biology, and biochemistry, providing tailored assay development services on a fee-for-service basis. Generated from the website

ACON Laboratories, headquartered in San Diego, California, specializes in providing innovative diagnostic products across various sectors, including point-of-care testing, immunoassays, molecular diagnostics, and animal health. The company is committed to enhancing healthcare through its diverse product lines, which are designed to meet the needs of healthcare professionals and consumers alike. With a focus on quality and reliability, ACON Laboratories offers a range of solutions, including blood glucose monitors, cholesterol testing kits, and veterinary diagnostics. Their commitment to advancing health outcomes is evident in their ongoing development of accessible and effective diagnostic tools for global markets. Generated from the website